4.4 Article

Computational analyses and prediction of guanylin deleterious SNPs

Journal

PEPTIDES
Volume 69, Issue -, Pages 92-102

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2015.04.013

Keywords

Guanylin; GUCA2A; Missense SNPs; Functional impact; Molecular dynamics

Funding

  1. CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
  2. CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)
  3. FAPDF (Fundacao de Amparo a Pesquisa do Distrito Federal)
  4. UCB (Universidade Catolica de Brasilia)

Ask authors/readers for more resources

Human guanylin, coded by the GUCA2A gene, is a member of a peptide family that activates intestinal membrane guanylate cyclase, regulating electrolyte and water transport in intestinal and renal epithelia. Deregulation of guanylin peptide activity has been associated with colon adenocarcinoma, adenoma and intestinal polyps. Besides, it is known that mutations on guanylin receptors could be involved in meconium ileus. However, there are no previous works regarding the alterations driven by single nucleotide polymorphisms in guanylin peptides. A comprehensive in silico analysis of missense SNPs present in the GUCA2A gene was performed taking into account 16 prediction tools in order to select the deleterious variations for further evaluation by molecular dynamics simulations (50 ns). Molecular dynamics data suggest that the three out of five variants (Cys104Arg, Cys112Ser and Cys115Tyr) have undergone structural modifications in terms of flexibility, volume and/or solvation. In addition, two nonsense SNPs were identified, both preventing the formation of disulfide bonds and resulting in the synthesis of truncated proteins. In summary the structural analysis of missense SNPs is important to decrease the number of potential mutations to be in vitro evaluated for associating them with some genetic diseases. In addition, data reported here could lead to a better understanding of structural and functional aspects of guanylin peptides. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available